134 related articles for article (PubMed ID: 32482664)
1. Splice of Life for Cancer: Missplicing of PPP2R5A by Mutant SF3B1 Leads to MYC Stabilization and Tumorigenesis.
O'Connor CM; Narla G
Cancer Discov; 2020 Jun; 10(6):765-767. PubMed ID: 32482664
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.
Liu Z; Yoshimi A; Wang J; Cho H; Chun-Wei Lee S; Ki M; Bitner L; Chu T; Shah H; Liu B; Mato AR; Ruvolo P; Fabbri G; Pasqualucci L; Abdel-Wahab O; Rabadan R
Cancer Discov; 2020 Jun; 10(6):806-821. PubMed ID: 32188705
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis identifies mutations in
Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
[TBL] [Abstract][Full Text] [Related]
4. Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
Liu B; Liu Z; Chen S; Ki M; Erickson C; Reis-Filho JS; Durham BH; Chang Q; de Stanchina E; Sun Y; Rabadan R; Abdel-Wahab O; Chandarlapaty S
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33031100
[TBL] [Abstract][Full Text] [Related]
5. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.
Yang JY; Huo YM; Yang MW; Shen Y; Liu DJ; Fu XL; Tao LY; He RZ; Zhang JF; Hua R; Jiang SH; Sun YW; Liu W
Mol Oncol; 2021 Nov; 15(11):3076-3090. PubMed ID: 33932092
[TBL] [Abstract][Full Text] [Related]
6. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.
Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648
[No Abstract] [Full Text] [Related]
7. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
[TBL] [Abstract][Full Text] [Related]
10. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
[TBL] [Abstract][Full Text] [Related]
12. Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome.
Clough CA; Pangallo J; Sarchi M; Ilagan JO; North K; Bergantinos R; Stolla MC; Naru J; Nugent P; Kim E; Stirewalt DL; Subramaniam AR; Abdel-Wahab O; Abkowitz JL; Bradley RK; Doulatov S
Blood; 2022 Mar; 139(13):2038-2049. PubMed ID: 34861039
[TBL] [Abstract][Full Text] [Related]
13. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing.
Zhang J; Xie J; Huang J; Liu X; Xu R; Tholen J; Galej WP; Tong L; Manley JL; Liu Z
Genes Dev; 2023 Dec; 37(21-24):968-983. PubMed ID: 37977822
[TBL] [Abstract][Full Text] [Related]
16. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation.
Dalton WB; Helmenstine E; Walsh N; Gondek LP; Kelkar DS; Read A; Natrajan R; Christenson ES; Roman B; Das S; Zhao L; Leone RD; Shinn D; Groginski T; Madugundu AK; Patil A; Zabransky DJ; Medford A; Lee J; Cole AJ; Rosen M; Thakar M; Ambinder A; Donaldson J; DeZern AE; Cravero K; Chu D; Madero-Marroquin R; Pandey A; Hurley PJ; Lauring J; Park BH
J Clin Invest; 2019 Aug; 129(11):4708-4723. PubMed ID: 31393856
[TBL] [Abstract][Full Text] [Related]
17. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.
Popli P; Richters MM; Chadchan SB; Kim TH; Tycksen E; Griffith O; Thaker PH; Griffith M; Kommagani R
Cell Death Dis; 2020 Oct; 11(10):842. PubMed ID: 33040078
[TBL] [Abstract][Full Text] [Related]
18. Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.
Obeng EA; Chappell RJ; Seiler M; Chen MC; Campagna DR; Schmidt PJ; Schneider RK; Lord AM; Wang L; Gambe RG; McConkey ME; Ali AM; Raza A; Yu L; Buonamici S; Smith PG; Mullally A; Wu CJ; Fleming MD; Ebert BL
Cancer Cell; 2016 Sep; 30(3):404-417. PubMed ID: 27622333
[TBL] [Abstract][Full Text] [Related]
19. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
Darman RB; Seiler M; Agrawal AA; Lim KH; Peng S; Aird D; Bailey SL; Bhavsar EB; Chan B; Colla S; Corson L; Feala J; Fekkes P; Ichikawa K; Keaney GF; Lee L; Kumar P; Kunii K; MacKenzie C; Matijevic M; Mizui Y; Myint K; Park ES; Puyang X; Selvaraj A; Thomas MP; Tsai J; Wang JY; Warmuth M; Yang H; Zhu P; Garcia-Manero G; Furman RR; Yu L; Smith PG; Buonamici S
Cell Rep; 2015 Nov; 13(5):1033-45. PubMed ID: 26565915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]